Liraglutide (Saxenda), which is administered as a daily injection, has also been proven to help individuals decrease weight without any weight regain
Galior, K., Grebe, S., & Singh, R
However, rare serious complications may occur in some patients receiving VPA chronically, including fatal haemorrhagic pancreatitis, bone marrow suppression, VPA-induced hepatotoxicity (VHT) and VPA-induced hyperammonaemic encephalopathy (VHE)
However, the FDA recently recategorized GHRP-2 as a significant risk (11)
Erratum in: Nat Commun
In totality, it was observed that DSIP may help to bring about a normalized sleeping pattern and eliminate possible dysfunction in sleep cycles